Paul Wachter Insider Trading $ADVM Adverum Biotechnologies, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul Wachter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Wachter. Paul Wachter is in WARNER MEDIA, LLC ($TWX) and Director in TIME WARNER INC. ($TWX) and Director in Adverum Biotechnologies, Inc. ($AAVL) and Director in Virgin America Inc. ($VA).
Paul Wachter in Adverum Biotechnologies, Inc.
Trading Symbol: ADVMIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul Wachter: Director
Holdings: 31,951 shares
Latest Transaction: Mar 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul Wachter in Adverum Biotechnologies, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2016 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 3,907 | 0 | 31,951 | 28 K to 32 K (+13.93 %) |
Feb 17 2016 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Option Exercise | A | 4.80 | 11,905 | 57,144 | 11,905 | |
Feb 17 2016 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 8,333 | 0 | 28,044 | 19.7 K to 28 K (+42.28 %) |
Feb 01 2016 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 3,334 | 0 | 19,711 | 16.4 K to 19.7 K (+20.36 %) |
Jan 04 2016 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 2,101 | 0 | 16,377 | 14.3 K to 16.4 K (+14.72 %) |
Dec 02 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 1,909 | 0 | 14,276 | 12.4 K to 14.3 K (+15.44 %) |
Nov 02 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 2,373 | 0 | 12,367 | 10 K to 12.4 K (+23.74 %) |
Oct 02 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 2,428 | 0 | 9,994 | 7.6 K to 10 K (+32.09 %) |
Sep 11 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 5,566 | 0 | 7,566 | 2 K to 7.6 K (+278.30 %) |
Jun 17 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 39.86 | 1,192 | 47,516 | 37,161 | 38.4 K to 37.2 K (-3.11 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 39.88 | 176 | 7,019 | 38,353 | 38.5 K to 38.4 K (-0.46 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 38.96 | 475 | 18,505 | 38,529 | 39 K to 38.5 K (-1.22 %) |
Jun 10 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 37.96 | 541 | 20,537 | 39,004 | 39.5 K to 39 K (-1.37 %) |
Jun 02 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 36.81 | 210 | 7,730 | 39,545 | 39.8 K to 39.5 K (-0.53 %) |
Jun 02 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 36.11 | 982 | 35,461 | 39,755 | 40.7 K to 39.8 K (-2.41 %) |
May 27 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 38.30 | 102 | 3,906 | 40,737 | 40.8 K to 40.7 K (-0.25 %) |
May 27 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 37.59 | 304 | 11,428 | 40,839 | 41.1 K to 40.8 K (-0.74 %) |
May 27 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 36.52 | 786 | 28,703 | 41,143 | 41.9 K to 41.1 K (-1.87 %) |
May 19 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 35.31 | 1,192 | 42,086 | 41,929 | 43.1 K to 41.9 K (-2.76 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 34.29 | 132 | 4,527 | 43,121 | 43.3 K to 43.1 K (-0.31 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 33.70 | 552 | 18,604 | 43,253 | 43.8 K to 43.3 K (-1.26 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 32.80 | 508 | 16,662 | 43,805 | 44.3 K to 43.8 K (-1.15 %) |
May 06 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 30.87 | 1,192 | 36,797 | 44,313 | 45.5 K to 44.3 K (-2.62 %) |
Apr 29 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 35.61 | 1,192 | 42,443 | 45,505 | 46.7 K to 45.5 K (-2.55 %) |
Apr 23 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Option Exercise | A | 39.35 | 7,000 | 275,450 | 7,000 | |
Apr 23 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Apr 21 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 40.19 | 1,192 | 47,910 | 46,697 | 47.9 K to 46.7 K (-2.49 %) |
Apr 15 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 40.74 | 24 | 978 | 47,889 | 47.9 K to 47.9 K (-0.05 %) |
Apr 15 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 39.85 | 338 | 13,468 | 47,913 | 48.3 K to 47.9 K (-0.70 %) |
Apr 15 2015 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Sell | S | 39.10 | 830 | 32,450 | 48,251 | 49.1 K to 48.3 K (-1.69 %) |
Page: 1